Cargando…

B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4(+) T cell responses in highly sensitized transplant recipients

Pretransplant desensitization with rituximab has been applied to preformed donor-specific anti-human leukocyte antigen antibody (DSA)-positive recipients for elimination of preformed DSA. We investigated the impact of pretransplant desensitization with rituximab on anti-donor T cell responses in DSA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Asuka, Ide, Kentaro, Tanaka, Yuka, Ohira, Masahiro, Tahara, Hiroyuki, Ohdan, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437972/ https://www.ncbi.nlm.nih.gov/pubmed/34518640 http://dx.doi.org/10.1038/s41598-021-97748-9

Ejemplares similares

Analysis of Risk Factors Affecting Incidence of Osteoporosis and Fragility Fractures in Liver Transplant Recipients
por: Yanagawa, Senichiro, et al.
Publicado: (2021)

Anti-CD137 mAb Deletes Both Donor CD4(+) and CD8(+) T Cells in Acute Graft-versus-host Disease
por: Kim, Juyang, et al.
Publicado: (2011)

Effect of Fc-γ Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation
por: Sakai, Hiroshi, et al.
Publicado: (2017)

Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma
por: Zhang, Jingzhe, et al.
Publicado: (2019)

LPS combined with CD47mAb enhances the anti‑osteosarcoma ability of macrophages
por: Yuan, Peng, et al.
Publicado: (2023)

Expression of Recipient CD47 on Rat Insulinoma Cell Xenografts Prevents Macrophage-Mediated Rejection through SIRPα Inhibitory Signaling in Mice
por: Teraoka, Yoshifumi, et al.
Publicado: (2013)

Complement system in Anti-CD20 mAb therapy for cancer: A mini-review
por: Gao, Yiwen
Publicado: (2023)

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
por: Bolaños-Mateo, Elixabet, et al.
Publicado: (2014)

Construction and characterization of an anti-CD20 mAb nanocomb with exceptionally excellent lymphoma-suppressing activity
por: Li, Hua-Fei, et al.
Publicado: (2015)

State of the art in anti-cancer mAbs
por: Chiavenna, S. M., et al.
Publicado: (2017)

Strategies for Deliberate Induction of Immune Tolerance in Liver Transplantation: From Preclinical Models to Clinical Application
por: Tanimine, Naoki, et al.
Publicado: (2020)

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
por: He, Li-Zhen, et al.
Publicado: (2013)

Anti-CD154 mAb and Rapamycin Induce T Regulatory Cell Mediated Tolerance in Rat-to-Mouse Islet Transplantation
por: Muller, Yannick D., et al.
Publicado: (2010)

The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent
por: He, Li-Zhen, et al.
Publicado: (2015)

Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment
por: Guo, Dan, et al.
Publicado: (2020)

Suppression of Rituximab-resistant B-cell lymphoma with a novel multi-component anti-CD20 mAb nanocluster
por: Li, Huafei, et al.
Publicado: (2015)

Norepinephrine inhibits CD8(+) T-cell infiltration and function, inducing anti-PD-1 mAb resistance in lung adenocarcinoma
por: Geng, Qishun, et al.
Publicado: (2023)

A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates
por: Ide, Kentaro, et al.
Publicado: (2015)

Immuno-PET Imaging of Atherosclerotic Plaques with [(89)Zr]Zr-Anti-CD40 mAb—Proof of Concept
por: Poels, Kikkie, et al.
Publicado: (2022)

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3(+)CD25(+)CD4(+) regulatory T cells
por: Ko, Kuibeom, et al.
Publicado: (2005)

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3(+)CD25(+)CD4(+) regulatory T cells
por: Ko, Kuibeom, et al.
Publicado: (2012)

Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells: A Comparison Study of Anti-CD80/86 mAbs and CTLA4-lg Costimulatory Blockade
por: Watanabe, M., et al.
Publicado: (2018)

Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment
por: Lee, Seok-Joo, et al.
Publicado: (2020)

A rare case of transient left ventricular apical ballooning syndrome following living donor liver transplantation: A case report and literature review
por: Tanaka, Asuka, et al.
Publicado: (2019)

Characterization of Two Novel mAbs Recognizing Different Epitopes on CD43
por: Kim, Soseul, et al.
Publicado: (2014)

Perioperative management with phosphodiesterase type 5 inhibitor and prostaglandin E1 for moderate portopulmonary hypertension following adult-to-adult living-donor liver transplantation: a case report
por: Onoe, Takashi, et al.
Publicado: (2018)

Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b(+)CD4(+) T Cells in the CNS during Progressive EAE
por: Mindur, John E., et al.
Publicado: (2014)

Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
por: Kroesen, Michiel, et al.
Publicado: (2016)

The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs
por: Golay, Josée, et al.
Publicado: (2020)

Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb
por: Morales-Kastresana, Aizea, et al.
Publicado: (2013)

Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C(44)Mab-108 for Immunohistochemistry
por: Suzuki, Hiroyuki, et al.
Publicado: (2023)

Impact of abdominal aortic calcification on clinical outcomes following initial hepatectomy for hepatocellular carcinoma: A retrospective cohort study
por: Imaoka, Yuki, et al.
Publicado: (2021)

Doxorubicin-loaded platelets conjugated with anti-CD22 mAbs: a novel targeted delivery system for lymphoma treatment with cardiopulmonary avoidance
por: Xu, Peipei, et al.
Publicado: (2017)

A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
por: Mikhael, Joseph, et al.
Publicado: (2020)

SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023)

Plant Recycling for Molecular Biofarming to Produce Recombinant Anti-Cancer mAb
por: Kim, Deuk-Su, et al.
Publicado: (2016)

Expression and in vitro function of anti-cancer mAbs in transgenic Arabidopsis thaliana
por: Song, Ilchan, et al.
Publicado: (2020)

Treatment of Marmoset Intracerebral Hemorrhage with Humanized Anti-HMGB1 mAb
por: Wang, Dengli, et al.
Publicado: (2022)

Biliary-duodenal anastomosis using magnetic compression following massive resection of small intestine due to strangulated ileus after living donor liver transplantation: a case report
por: Saito, Ryusuke, et al.
Publicado: (2017)

Heterophile carbohydrate antigen N‐glycolylneuraminic acid as a potential biomarker in patients with hepatocellular carcinoma
por: Akimoto, Shuji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e0iilnif0r16ck3ibhu8h54c67